Revvity stock heads into the open after a 2.5% Nasdaq drop
Published on 09/10/2026 at 07:03 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Revvity stock closed at USD 123.85 on the Nasdaq on September 9, 2026, down 2.5% from the prior close of USD 127.08. The stock lagged the S&P 500 index, which also retreated on September 9, 2026, but by a smaller percentage.
September 9, 2026 in numbers
Revvity Inc. (ISIN US76155R1086, NYSE: RVTY) recorded an intraday high and low on September 9, 2026 that framed its USD 123.85 close, with the low remaining above the recent 52-week floor and the high below the 52-week peak, according to Nasdaq data at Yahoo Finance. The previous close stood at USD 127.08, making the confirmed 2.5% decline on September 9, 2026 a clear negative session. Against trailing total returns as of September 9, 2026, the single-session move marked a setback versus the S&P 500 benchmark, which fell less sharply that day.
As GuruFocus reported on September 9, 2026, UBS assumed coverage of Revvity with a Neutral rating and set a price target of USD 140, a call that highlighted the stock as modestly overvalued versus an intrinsic value estimate and added an analyst catalyst to the day. In a separate note, Benzinga highlighted Revvity's agreement to acquire Human Cell Design to strengthen its position in human-relevant cell models for metabolic disease drug discovery, a strategic move that framed investor debate about future growth and valuation on September 9, 2026.
Today’s catalysts for Revvity
Looking at today, September 10, 2026, company-specific news continues to shape expectations ahead of the open. As Revvity announced on September 10, 2026, it plans to acquire Human Cell Design to advance human-relevant cell models for metabolic disease drug discovery, and this transaction remains a central strategic theme for the stock today. In addition, Seeking Alpha documented Revvity’s presentation at the Wells Fargo 21st Annual Healthcare Conference on September 9, 2026, an investor-facing event whose messages and guidance continue to resonate into today’s session. According to Yahoo Finance’s earnings overview, the next estimated earnings date for Revvity is October 26, 2026, so today’s trading will focus more on digesting the new acquisition and analyst coverage than on imminent quarterly results.
